Menu

A dozen drugmakers have agreed to negotiate prices with the federal government as part of the second round of Medicare drug price talks under the Inflation Reduction Act.

Drugmakers Agree to Take Part in Second Round of IRA’s Medicare Drug Price Talks

March 20, 2025 Shannon Young, Managing Editor 340B Report Views

The manufacturers behind 15 drugs selected for the second round of Medicare drug price negotiations under the Inflation Reduction Act [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Vermont House Passes Contract Pharmacy Access Bill, While U.S. House Republican Introduces ‘No 340B Savings for Transgender Care Act’

Trump’s HHS Continues to Oppose Unilateral Drugmaker 340B Rebates in Kalderos Lawsuit